• Users Online: 180
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Drug-resistant pathogens in community-acquired pneumonia

Uranga Ane, Restrepo Marcos I, Chalmers James D, Blasi Francesco, Aliberti Stefano

Year : 2015| Volume: 2| Issue : 4 | Page no: 123-130

   This article has been cited by
1 Identification of hospitalized patients with community-acquired infection in whom treatment guidelines do not apply: a validated model
Teresa Cardoso,Pedro Pereira Rodrigues,Cristina Nunes,Mónica Almeida,Joana Cancela,Fernando Rosa,Nuno Rocha-Pereira,Inês Ferreira,Filipa Seabra-Pereira,Prudência Vaz,Liliana Carneiro,Carina Andrade,Justin Davis,Ana Marçal,N Deborah Friedman
Journal of Antimicrobial Chemotherapy. 2019;
[Pubmed]  [Google Scholar]
2 Comparative efficacy and safety analysis of CSE-1034: An open labeled phase III study in community acquired pneumonia
Manu Chaudhary,Shiekh G. Ayub,Mohd A. Mir
Journal of Infection and Public Health. 2018; 11(5): 691
[Pubmed]  [Google Scholar]
3 Integrated safety summary of phase II and III studies comparing oral nemonoxacin and levofloxacin in community-acquired pneumonia
Shih-Lung Cheng,Ren-Guang Wu,Yin-Ching Chuang,Wann-Cherng Perng,Shih-Ming Tsao,Yu-Ting Chang,Li-Wen Chang,Ming-Chu Hsu
Journal of Microbiology, Immunology and Infection. 2018;
[Pubmed]  [Google Scholar]


Read this article